Dr. Michael Stiefel 

Michael F. Stiefel, MD PhD FAANS
Director, Capital Institute for Neurosciences
Director, Stroke and Cerebrovascular Center

Dr. Stiefel is a fellowship trained, board certified neurosurgeon specializing in cerebrovascular and endovascular neurosurgery, as well as skull base surgery and surgery for brain tumors. As director of the Capital Institute for Neurosciences, he oversees all neurosurgical and neurological services offered at the Institute as well as the hospital’s Comprehensive Stroke Program, Neurosurgical Intensive Care Unit and Stroke Units, and neuroscience research activities.

Dr. Stiefel received his MD and PhD from the Medical College of Virginia. He completed his neurosurgery training at the University of Pennsylvania. While at the University of Pennsylvania, he completed training in diagnostic neuroradiology and was the Groff Cerebrovascular Research Fellow as well as an NIH research fellow. He then went on to complete a fellowship in endovascular neurosurgery at the Barrow Neurological Institute in Phoenix, Arizona.

Dr. Stiefel joined Capital Health from Westchester Medical Center in New York where he was director of the Neurovascular Institute, director of Cerebrovascular and Endovascular Neurosurgery and co-director of Neuro-Critical Care. While at Westchester, he established one of the largest comprehensive neurovascular programs for the treatment of stroke, aneurysms, and brain hemorrhages in the New York/Connecticut region and Hudson Valley. Prior to that, he served as director of the Comprehensive Cerebrovascular & Endovascular Neurosurgery Program and associate director of Neuro-Critical Care at the University of Pennsylvania.

As a cerebrovascular neurosurgeon, Dr. Stiefel offers surgical treatments using microsurgical and endovascular techniques to treat cerebral aneurysms, acute stroke, subarachnoid hemorrhage, arteriovenous malformations (AVMs), arteriovenous fistulas (AVFs), carotid stenosis, intracranial stenosis, and cavernous malformations.

Dr. Stiefel is a nationally recognized researcher in the area of stroke and has been at the forefront of trialing new devices for the treatment of ischemic stroke and cerebral aneurysms. He was first in the New York region to use the Solitaire Stent-Triever for stroke after FDA approval and is currently one of the most experienced users of the Pipeline Embolization Device for the treatment of aneurysms in the New York area.

Back to top